REG - FIL Limited Medtronic, Inc. - Form 8.3 - COVIDIEN PLC <Origin Href="QuoteRef">MDT.N</Origin>

MedtronicAnnouncement

29/10/2014 10:11

RNS Number : 6906T
FIL Limited
07 October 2014
FORM 8.3
 IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2007 (AS AMENDED)
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1)
 FMR LLC and/or one or more of its direct or indirect subsidiaries
And
FIL Limited and/or one or more of its direct and indirect subsidiaries
Company dealt in
COVIDIEN PLC
Class of relevant security to which the dealings being disclosed relate(Note 2)
Ordinary shares
Date of dealing
06-October-14
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security
dealt in(Note 3)
Long
Short
Number (%)
Number (%)
(1) Relevant securities 
19,703,471 4.36

(2) Derivatives (other than options)
 
 
(3) Options and agreements to purchase/sell
 
 
Total
19,703,471 4.36
 
b) Interests and short positions in relevant securities of the company, other than the
class dealt in(Note 3)
Class of relevant security:
Long
Short
Number (%)
Number (%)
(91) Relevant securities 
 
 
(2) Derivatives (other than options)
 
 
(3) Options and agreements to purchase/sell
 
 
Total
 
 
3. DEALINGS(Note 4)
(91) Purchases and sales
Purchase/sale
Number of securities
Price per unit
Sale
639,300
94.1423 USD/ Share
Buy
4,477
94.1144 USD/ Share
Buy
28,800
94.2000 USD/ Share
Buy
800
94.0962 USD/ Share
Buy
1,900
94.0205 USD/ Share
Buy
63,622
94.1968 USD/ Share
Buy
11,700
94.0077 USD/ Share
Buy
1,350
94.0985 USD/ Share
Buy
952
94.0750 USD/ Share
Buy
152
94.1000 USD/ Share
Buy
2,300
93.9878 USD/ Share
Buy
600
93.9900 USD/ Share
Buy
50,347
94.0300 USD/ Share
Buy
639,300
94.1423 USD/ Share
Buy
1,300
94.1465 USD/ Share
Buy
42,600
94.1185 USD/ Share
Sale
48,724
94.0300 USD/ Share
Sale
400
93.9000 USD/ Share
Sale
1,100
94.0027 USD/ Share
Sale
9,639
94.0200 USD/ Share
Sale
5,549
94.0394 USD/ Share
Sale
3,311
94.0140 USD/ Share
Sale
5,135
93.8962 USD/ Share
Sale
3,600
93.8878 USD/ Share
Sale
900
93.9033 USD/ Share
Sale
3,339
93.9083 USD/ Share
Sale
500
93.8550 USD/ Share
Sale
500,000
94.0278 USD/ Share
Sale
38,319
94.0092 USD/ Share
Sale
9,600
93.9848 USD/ Share
Sale
40,181
93.9593 USD/ Share
Sale
99,774
93.9155 USD/ Share
Sale
1,800
93.8589 USD/ Share
Sale
3,000
93.8090 USD/ Share
Sale
5,805
93.8902 USD/ Share
Sale
1,300
93.9146 USD/ Share
Buy
100
94.1700 USD/ Share
Sale
100
93.9900 USD/ Share
Sale
100
94.0000 USD/ Share
Sale
224
93.8396 USD/ Share
Sale
22
93.9300 USD/ Share
Buy
400
93.9000 USD/ Share
Buy
1
93.7100 USD/ Share
Buy
33
93.9300 USD/ Share
Buy
19
93.8000 USD/ Share
Buy
4
93.8300 USD/ Share
(b) Derivatives transactions (other than options transactions)
Product name, 
e.g. CFD
Nature of transaction (Note 6)
Number of securities (Note 7)
Price per unit (Note 5)




(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name,
e.g. call option
Writing, selling, purchasing, varying etc.
Number of securities to which the option relates (Note 7)
Exercise
price 
Type, e.g. American, European etc.
Expiry 
date
Option money
paid/received per unit (Note 5) 







(ii) Exercising
Product name, e.g. call option
Number of securities 
Exercise price per unit (Note 5)


(d) Other dealings (including transactions in respect of new securities)(Note 4)
Nature of transaction (Note 8)
Details
Price per unit (if applicable)(Note 5)


4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. 
Is a Supplemental Form 8 attached?(Note 9)NO
Date of disclosure
07 October 2014
Contact name
Nevelina Rousseva-Gasnier
Telephone number
+44 (0)1737 837216
If a connected EFM, name of offeree/offeror with which connected
N/A
If a connected EFM, state nature of connection (Note 10)
N/A

This information is provided by RNS
The company news service from the London Stock Exchange
  END
ISELLFFSITLDIIS